05.16.11
Mary G. Foster, PharmD has been appointed corporate vice president of Quality and Regulatory Affairs at Aphena Pharma Solutions, effective June 1st. In this role, Ms. Foster will help Aphena to shape and plan long-term goals for the company, and further enhance adherence to the highest quality and regulatory standards.
Ms. Foster has more than 25 years of experience, and joins the company from Catalent Pharma Solutions, where she served as vice president of quality. In that role, she was responsible for creating a global cGMP program and for training and developing connections within the industry and worldwide regulatory bodies to ensure continuous understanding and improvement of quality processes.
“We’re so pleased to have Mary join the company. It is our intent to employ the industry’s best and brightest, Mary certainly fits that category,” said Aphena president and chief executive officer, Renard Jackson. “She shares our company’s values, our focus on client expectations, and our vision for the future as a single-source industry leader.”
Ms. Foster has more than 25 years of experience, and joins the company from Catalent Pharma Solutions, where she served as vice president of quality. In that role, she was responsible for creating a global cGMP program and for training and developing connections within the industry and worldwide regulatory bodies to ensure continuous understanding and improvement of quality processes.
“We’re so pleased to have Mary join the company. It is our intent to employ the industry’s best and brightest, Mary certainly fits that category,” said Aphena president and chief executive officer, Renard Jackson. “She shares our company’s values, our focus on client expectations, and our vision for the future as a single-source industry leader.”
